Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
A single dose study with the inhaled anti-inflammatory agent PF-03715455 to establish if it
has anti-inflammatory activity following a challenge with LPS. Inhaled LPS invokes an acute
inflammatory response in the lung which can be seen in induced sputum. PH-0797804 is an
internal control for the study.